CA3095273A1 - A sunscreen composition - Google Patents
A sunscreen composition Download PDFInfo
- Publication number
- CA3095273A1 CA3095273A1 CA3095273A CA3095273A CA3095273A1 CA 3095273 A1 CA3095273 A1 CA 3095273A1 CA 3095273 A CA3095273 A CA 3095273A CA 3095273 A CA3095273 A CA 3095273A CA 3095273 A1 CA3095273 A1 CA 3095273A1
- Authority
- CA
- Canada
- Prior art keywords
- resorcinol
- composition
- sunscreen
- sunscreen composition
- per
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 167
- 230000000475 sunscreen effect Effects 0.000 title claims abstract description 70
- 239000000516 sunscreening agent Substances 0.000 title claims abstract description 70
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 claims abstract description 46
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 31
- 239000000194 fatty acid Substances 0.000 claims abstract description 31
- 229930195729 fatty acid Natural products 0.000 claims abstract description 31
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 31
- 239000000344 soap Substances 0.000 claims abstract description 29
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 claims abstract description 20
- PQSXNIMHIHYFEE-UHFFFAOYSA-N 4-(1-phenylethyl)benzene-1,3-diol Chemical compound C=1C=C(O)C=C(O)C=1C(C)C1=CC=CC=C1 PQSXNIMHIHYFEE-UHFFFAOYSA-N 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 229940106025 phenylethyl resorcinol Drugs 0.000 claims abstract description 13
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims abstract description 9
- 230000004224 protection Effects 0.000 claims abstract description 8
- 239000004101 4-Hexylresorcinol Substances 0.000 claims description 20
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 claims description 20
- 235000019360 4-hexylresorcinol Nutrition 0.000 claims description 20
- 229960003258 hexylresorcinol Drugs 0.000 claims description 20
- VGMJYYDKPUPTID-UHFFFAOYSA-N 4-ethylbenzene-1,3-diol Chemical compound CCC1=CC=C(O)C=C1O VGMJYYDKPUPTID-UHFFFAOYSA-N 0.000 claims description 18
- 239000002736 nonionic surfactant Substances 0.000 claims description 16
- 229920000642 polymer Polymers 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 claims description 6
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 claims description 6
- 239000007854 depigmenting agent Substances 0.000 claims description 6
- 150000002191 fatty alcohols Chemical group 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- FNYDIAAMUCQQDE-UHFFFAOYSA-N 4-methylbenzene-1,3-diol Chemical compound CC1=CC=C(O)C=C1O FNYDIAAMUCQQDE-UHFFFAOYSA-N 0.000 claims description 4
- LNFVQIGQENWZQN-UHFFFAOYSA-N 4-propan-2-ylbenzene-1,3-diol Chemical compound CC(C)C1=CC=C(O)C=C1O LNFVQIGQENWZQN-UHFFFAOYSA-N 0.000 claims description 4
- DJDHQJFHXLBJNF-UHFFFAOYSA-N 4-propylbenzene-1,3-diol Chemical compound CCCC1=CC=C(O)C=C1O DJDHQJFHXLBJNF-UHFFFAOYSA-N 0.000 claims description 3
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 claims description 2
- PFPZRMUCMKVUEX-UHFFFAOYSA-N 4-heptylbenzene-1,3-diol Chemical compound CCCCCCCC1=CC=C(O)C=C1O PFPZRMUCMKVUEX-UHFFFAOYSA-N 0.000 claims description 2
- JPUHXNRAGDKQRD-UHFFFAOYSA-N 4-octylbenzene-1,3-diol Chemical compound CCCCCCCCC1=CC=C(O)C=C1O JPUHXNRAGDKQRD-UHFFFAOYSA-N 0.000 claims description 2
- PJHYOCWMKYASAB-UHFFFAOYSA-N 4-pentylbenzene-1,3-diol Chemical compound CCCCCC1=CC=C(O)C=C1O PJHYOCWMKYASAB-UHFFFAOYSA-N 0.000 claims description 2
- -1 2-ethylhexyl Chemical group 0.000 description 19
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 229920001577 copolymer Polymers 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 8
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 7
- 229920006037 cross link polymer Polymers 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 230000005855 radiation Effects 0.000 description 7
- 238000002834 transmittance Methods 0.000 description 7
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 6
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 239000008117 stearic acid Substances 0.000 description 5
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 235000021314 Palmitic acid Nutrition 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 238000011065 in-situ storage Methods 0.000 description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 4
- 239000004926 polymethyl methacrylate Substances 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 3
- JYCQQPHGFMYQCF-UHFFFAOYSA-N 4-tert-Octylphenol monoethoxylate Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCO)C=C1 JYCQQPHGFMYQCF-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000037338 UVA radiation Effects 0.000 description 3
- 125000005907 alkyl ester group Chemical group 0.000 description 3
- 229960005193 avobenzone Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 3
- 229920002113 octoxynol Polymers 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 2
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 2
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 108010030545 N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide Proteins 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- HEAHZSUCFKFERC-LRVMPXQBSA-N [(2e)-2-[[4-[(z)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C/C(C=C1)=CC=C1\C=C/1C(=O)C2(CS(O)(=O)=O)CCC\1C2(C)C HEAHZSUCFKFERC-LRVMPXQBSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 229940072107 ascorbate Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 2
- 229940110830 beheneth-25 methacrylate Drugs 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 2
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 2
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 2
- GLCJMPWWQKKJQZ-UHFFFAOYSA-L disodium;2-[4-(4,6-disulfonato-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonate;hydron Chemical compound [Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O GLCJMPWWQKKJQZ-UHFFFAOYSA-L 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229960003747 ecamsule Drugs 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 235000003969 glutathione Nutrition 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- NITYDPDXAAFEIT-DYVFJYSZSA-N ilomastat Chemical compound C1=CC=C2C(C[C@@H](C(=O)NC)NC(=O)[C@H](CC(C)C)CC(=O)NO)=CNC2=C1 NITYDPDXAAFEIT-DYVFJYSZSA-N 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- XMTUJCWABCYSIV-UHFFFAOYSA-N octane-2,3-diol Chemical compound CCCCCC(O)C(C)O XMTUJCWABCYSIV-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229940073743 steareth-20 methacrylate Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- VEAFKIYNHVBNIP-UHFFFAOYSA-N 1,3-Diphenylpropane Chemical class C=1C=CC=CC=1CCCC1=CC=CC=C1 VEAFKIYNHVBNIP-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- HDIFHQMREAYYJW-FMIVXFBMSA-N 2,3-dihydroxypropyl (e)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C\CCCCCCCC(=O)OCC(O)CO HDIFHQMREAYYJW-FMIVXFBMSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 1
- JKXYOQDLERSFPT-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-octadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO JKXYOQDLERSFPT-UHFFFAOYSA-N 0.000 description 1
- KIOWXTOCDZJCBM-UHFFFAOYSA-N 2-docosoxyethyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCOC(=O)C(C)=C KIOWXTOCDZJCBM-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- OJIBJRXMHVZPLV-UHFFFAOYSA-N 2-methylpropyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(C)C OJIBJRXMHVZPLV-UHFFFAOYSA-N 0.000 description 1
- KOZZOZYINRDZOU-UHFFFAOYSA-N 2-octadecoxyethyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOCCOC(=O)C(C)=C KOZZOZYINRDZOU-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- WMJBVALTYVXGHW-UHFFFAOYSA-N 3,3-diphenylprop-2-enoic acid Chemical compound C=1C=CC=CC=1C(=CC(=O)O)C1=CC=CC=C1 WMJBVALTYVXGHW-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- GFBCWCDNXDKFRH-UHFFFAOYSA-N 4-(oxan-2-yloxy)phenol Chemical compound C1=CC(O)=CC=C1OC1OCCCC1 GFBCWCDNXDKFRH-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 150000005422 4-hydroxybenzoic acid derivatives Chemical class 0.000 description 1
- AMEMLELAMQEAIA-UHFFFAOYSA-N 6-(tert-butyl)thieno[3,2-d]pyrimidin-4(3H)-one Chemical compound N1C=NC(=O)C2=C1C=C(C(C)(C)C)S2 AMEMLELAMQEAIA-UHFFFAOYSA-N 0.000 description 1
- 239000004251 Ammonium lactate Substances 0.000 description 1
- 235000003911 Arachis Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 1
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 229940048299 acetylated lanolin alcohols Drugs 0.000 description 1
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 1
- 229960002916 adapalene Drugs 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 229940059265 ammonium lactate Drugs 0.000 description 1
- 235000019286 ammonium lactate Nutrition 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 229940053195 antiepileptics hydantoin derivative Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- RZOBLYBZQXQGFY-HSHFZTNMSA-N azanium;(2r)-2-hydroxypropanoate Chemical compound [NH4+].C[C@@H](O)C([O-])=O RZOBLYBZQXQGFY-HSHFZTNMSA-N 0.000 description 1
- 229960002255 azelaic acid Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical class O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229910000286 fullers earth Inorganic materials 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 150000001469 hydantoins Chemical class 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940033357 isopropyl laurate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- LJZULWUXNKDPCG-UHFFFAOYSA-N nonane-1,2-diol Chemical compound CCCCCCCC(O)CO LJZULWUXNKDPCG-UHFFFAOYSA-N 0.000 description 1
- OXGBCSQEKCRCHN-UHFFFAOYSA-N octadecan-2-ol Chemical compound CCCCCCCCCCCCCCCCC(C)O OXGBCSQEKCRCHN-UHFFFAOYSA-N 0.000 description 1
- UJWVPVVMYOBBIY-UHFFFAOYSA-N octane-3,4-diol Chemical compound CCCCC(O)C(O)CC UJWVPVVMYOBBIY-UHFFFAOYSA-N 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000012463 white pigment Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/591—Mixtures of compounds not provided for by any of the codes A61K2800/592 - A61K2800/596
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to a sunscreen composition. Particularly, the sunscreen composition relates to providing improved ultraviolet A protection factor (UVAPF). The composition comprises UVA organic sunscreen, 2- ethylhexyl 2-cyano-3,3-diphenylacrylate, a compound selected from resorcinol, phenylethyl resorcinol, 4-alkyl substituted resorcinol and mixtures thereof, fatty acid and soap.
Description
A Sunscreen Composition Field of the invention The present invention relates to a sunscreen composition. Particularly, the present invention relates to a sunscreen composition that provides improved ultraviolet (UV) A protection factor (UVAPF).
Background of the invention People often try to take care of themselves and of their external surfaces e.g.
skin and scalp including hairs, with a desire of enjoying healthy lifestyle.
Specific skin related issues that people are concerned about include healthy and infection-free skin, good skin tone, adequate moisturization and protection from UV radiation contained in the sunlight.
Sunlight comprises infrared region (700 nm to 1 mm), visible region (380 to nm) and UV region (100 to 400 nm). The UV region is composed of UVC (100 to 280 nm), UVB (280 to 315 nm) and UVA (315 to 400 nm). While the human body needs some UV radiation for synthesis / maintenance of adequate amount of vitamin D, harmful effects of UV typically outweighs the benefits. An excessive exposure to UVB is said to cause direct damage to DNA and cause sunburn too; and an excessive exposure to UVA is said to give rise to immediate pigment darkening and delayed tanning effect. In addition, UVA is also said to cause DNA damages via oxidation reactions that involve reactive oxygen species (Zhang et al., 1997, Free Radical Biology & Medicine, 23, 980-985).
It is for reasons like these that people are inclined towards avoiding exposure to sunlight as much as possible. However, in many instances, avoiding exposure to sunlight is very difficult and at times; impossible. It is for such unavoidable reasons, people tend to make use of various topical compositions e.g.
sunscreen composition, that offer at least some protection against unwanted
Background of the invention People often try to take care of themselves and of their external surfaces e.g.
skin and scalp including hairs, with a desire of enjoying healthy lifestyle.
Specific skin related issues that people are concerned about include healthy and infection-free skin, good skin tone, adequate moisturization and protection from UV radiation contained in the sunlight.
Sunlight comprises infrared region (700 nm to 1 mm), visible region (380 to nm) and UV region (100 to 400 nm). The UV region is composed of UVC (100 to 280 nm), UVB (280 to 315 nm) and UVA (315 to 400 nm). While the human body needs some UV radiation for synthesis / maintenance of adequate amount of vitamin D, harmful effects of UV typically outweighs the benefits. An excessive exposure to UVB is said to cause direct damage to DNA and cause sunburn too; and an excessive exposure to UVA is said to give rise to immediate pigment darkening and delayed tanning effect. In addition, UVA is also said to cause DNA damages via oxidation reactions that involve reactive oxygen species (Zhang et al., 1997, Free Radical Biology & Medicine, 23, 980-985).
It is for reasons like these that people are inclined towards avoiding exposure to sunlight as much as possible. However, in many instances, avoiding exposure to sunlight is very difficult and at times; impossible. It is for such unavoidable reasons, people tend to make use of various topical compositions e.g.
sunscreen composition, that offer at least some protection against unwanted
2 effects caused by excessive exposure to UV radiations contained in sunlight.
These compositions comprise sunscreens that absorb UV radiations and prevent them from reaching a surface e.g. skin of a user on which the composition is applied.
Organic sunscreens e.g. 4-tert-butyl-4'-methoxydibenzoylmethane (BMDM) absorb the UVA radiation. The ability of a sunscreen to provide protection by absorbing UVA radiation is expressed in terms of UVA protection factor (UVAPF). On the other hand, organic sunscreens, e.g. 2-ethylhexyl 2-cyano-
These compositions comprise sunscreens that absorb UV radiations and prevent them from reaching a surface e.g. skin of a user on which the composition is applied.
Organic sunscreens e.g. 4-tert-butyl-4'-methoxydibenzoylmethane (BMDM) absorb the UVA radiation. The ability of a sunscreen to provide protection by absorbing UVA radiation is expressed in terms of UVA protection factor (UVAPF). On the other hand, organic sunscreens, e.g. 2-ethylhexyl 2-cyano-
3,3-diphenylacrylate (OCR) and octyl methoxycinnamate (MCX) absorb the UVB radiation. The ability of a sunscreen to provide protection by absorbing UVB radiation is expressed in terms of sun protection factor (SPF).
EP 2 431 021 (Unilever) discloses a high SPF sunscreen composition comprising less than 8% total organic sunscreens comprising dibenzoylmethane or its derivative, an oil soluble UV-B organic sunscreen, non-ionic surfactant selected from the class of fatty alcohol ethoxylates with saturated carbon chain and having HLB higher than 15.5 or from the class of fatty alcohol ethoxylates with unsaturated carbon chain with HLB higher than 12, a polymer of the class of acrylate/R-methacrylate copolymer; or an acrylate/
R-alkyl acrylate crosspolymer and a cosmetically acceptable base. The compositions disclosed therein aim at providing a SPF higher than 15 without compromising on the desired skin sensorial properties.
WO 03/ 080009 (Unilever) discloses cosmetic compositions comprising organic sunscreens along with a 4-substituted resorcinol derivatives in a cosmetically acceptable base. The compositions exhibit improved storage stability and oxidative stability. WO 03/080009 particularly discloses a combination of butylmethoxy dibenzoylmethane, octyl methoxycinnamate, stearic acid and 4-substituted resorcinol.
EP 2 431 021 (Unilever) discloses a high SPF sunscreen composition comprising less than 8% total organic sunscreens comprising dibenzoylmethane or its derivative, an oil soluble UV-B organic sunscreen, non-ionic surfactant selected from the class of fatty alcohol ethoxylates with saturated carbon chain and having HLB higher than 15.5 or from the class of fatty alcohol ethoxylates with unsaturated carbon chain with HLB higher than 12, a polymer of the class of acrylate/R-methacrylate copolymer; or an acrylate/
R-alkyl acrylate crosspolymer and a cosmetically acceptable base. The compositions disclosed therein aim at providing a SPF higher than 15 without compromising on the desired skin sensorial properties.
WO 03/ 080009 (Unilever) discloses cosmetic compositions comprising organic sunscreens along with a 4-substituted resorcinol derivatives in a cosmetically acceptable base. The compositions exhibit improved storage stability and oxidative stability. WO 03/080009 particularly discloses a combination of butylmethoxy dibenzoylmethane, octyl methoxycinnamate, stearic acid and 4-substituted resorcinol.
4 PCT/EP2019/059662 WO 11/147738 (Unilever) relates to sunscreen compositions that provide SPF
(equal to or greater than 15) and high UVAPF (equal to or higher than 4). WO
11/ 147738 discloses a solid sunscreen composition comprising butylmethoxy dibenzoylmethane, a nonionic surfactant of select class, a polymer of select class in a cosmetically acceptable base. WO 11/147738 further discloses a non-solid sunscreen composition comprising dibenzoylmethane or its derivative, a nonionic surfactant of select class, a fatty acid and a cosmetically acceptable base.
WO 16/142129 (Unilever) discloses a combination of 012-020 fatty acid with 012-020 fatty acid soap, white pigment e.g. titanium dioxide in a cosmetically acceptable carrier wherein the mole ratio of soap to fatty acid is from 0.23 to 0.5. WO 16/142129 solves the problem of providing photoprotection whilst maintaining the sensorial properties of the compositions when pigments like titanium dioxide are added to fatty acid containing compositions.
Despite efforts thus far, compositions that provide improved UVAPF remains a topic of interest.
Need therefore exists to develop a sunscreen composition that provides improved UVAPF.
It has now been found that a composition comprising a compound selected from resorcinol, phenylethyl resorcinol, 4-alkyl substituted resorcinol and mixtures thereof along with UVA organic sunscreen, UVB organic sunscreen of select class, fatty acid and soap, provides improved UVAPF.
Summary of the invention In a first aspect, the present invention relates to a sunscreen composition comprising:
a. 0.1 to 5 wt% UVA organic sunscreen, b. 0.1 to 10 wt% 2-ethylhexyl 2-cyano-3,3-diphenylacrylate, c. 0.1 to 2.5 wt% of a compound selected from resorcinol, phenylethyl resorcinol, 4-alkyl substituted resorcinol and mixtures thereof, d. 4 to 25 wt% fatty acid; and e. 0.1 to 10 wt% soap.
In a second aspect, the present invention relates to a method of providing improved UVAPF, the method comprising applying on the skin a sunscreen composition of the first aspect and optionally, rinsing with water.
In a third aspect, the present invention relates to use of the composition of the first aspect for providing improved UVAPF.
Detailed description of the invention Any feature of one aspect of the present invention may be utilized in any other aspect of the invention. The word "comprising" is intended to mean "including"
but not necessarily "consisting of" or "composed of." In other words, the listed steps or options need not be exhaustive. Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material or conditions of reaction, physical properties of materials and/or use are to be understood as modified by the word "about". Numerical ranges expressed in the format "x to y" are understood to include x and y. When for a specific feature multiple preferred ranges are described in the format "x to y", it is understood that all ranges combining the different endpoints are also contemplated.
Unless specified otherwise, amounts as used herein are expressed in percentage by weight based on total weight of the composition and is abbreviated as "wt%".
The use of any and all examples or exemplary language e.g. "such as" provided herein is intended merely to better illuminate the invention and does not in any way limit the scope of the invention otherwise claimed.
(equal to or greater than 15) and high UVAPF (equal to or higher than 4). WO
11/ 147738 discloses a solid sunscreen composition comprising butylmethoxy dibenzoylmethane, a nonionic surfactant of select class, a polymer of select class in a cosmetically acceptable base. WO 11/147738 further discloses a non-solid sunscreen composition comprising dibenzoylmethane or its derivative, a nonionic surfactant of select class, a fatty acid and a cosmetically acceptable base.
WO 16/142129 (Unilever) discloses a combination of 012-020 fatty acid with 012-020 fatty acid soap, white pigment e.g. titanium dioxide in a cosmetically acceptable carrier wherein the mole ratio of soap to fatty acid is from 0.23 to 0.5. WO 16/142129 solves the problem of providing photoprotection whilst maintaining the sensorial properties of the compositions when pigments like titanium dioxide are added to fatty acid containing compositions.
Despite efforts thus far, compositions that provide improved UVAPF remains a topic of interest.
Need therefore exists to develop a sunscreen composition that provides improved UVAPF.
It has now been found that a composition comprising a compound selected from resorcinol, phenylethyl resorcinol, 4-alkyl substituted resorcinol and mixtures thereof along with UVA organic sunscreen, UVB organic sunscreen of select class, fatty acid and soap, provides improved UVAPF.
Summary of the invention In a first aspect, the present invention relates to a sunscreen composition comprising:
a. 0.1 to 5 wt% UVA organic sunscreen, b. 0.1 to 10 wt% 2-ethylhexyl 2-cyano-3,3-diphenylacrylate, c. 0.1 to 2.5 wt% of a compound selected from resorcinol, phenylethyl resorcinol, 4-alkyl substituted resorcinol and mixtures thereof, d. 4 to 25 wt% fatty acid; and e. 0.1 to 10 wt% soap.
In a second aspect, the present invention relates to a method of providing improved UVAPF, the method comprising applying on the skin a sunscreen composition of the first aspect and optionally, rinsing with water.
In a third aspect, the present invention relates to use of the composition of the first aspect for providing improved UVAPF.
Detailed description of the invention Any feature of one aspect of the present invention may be utilized in any other aspect of the invention. The word "comprising" is intended to mean "including"
but not necessarily "consisting of" or "composed of." In other words, the listed steps or options need not be exhaustive. Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material or conditions of reaction, physical properties of materials and/or use are to be understood as modified by the word "about". Numerical ranges expressed in the format "x to y" are understood to include x and y. When for a specific feature multiple preferred ranges are described in the format "x to y", it is understood that all ranges combining the different endpoints are also contemplated.
Unless specified otherwise, amounts as used herein are expressed in percentage by weight based on total weight of the composition and is abbreviated as "wt%".
The use of any and all examples or exemplary language e.g. "such as" provided herein is intended merely to better illuminate the invention and does not in any way limit the scope of the invention otherwise claimed.
5 .. In a first aspect, the present invention relates to a sunscreen composition comprising:
a. 0.1 to 5 wt% UVA organic sunscreen, b. 0.1 to 10 wt% 2-ethylhexyl 2-cyano-3,3-diphenylacrylate, c. 0.1 to 2.5 wt% of a compound selected from resorcinol, phenylethyl resorcinol, 4-alkyl substituted resorcinol and mixtures thereof, d. 4 to 25 wt% fatty acid; and e. 0.1 to 10 wt% soap.
UVA organic sunscreen The composition according to the present invention (the composition) comprises UVA organic sunscreen that absorbs UVA radiations and prevents them from reaching a surface e.g. skin of a user.
Examples of sunscreens that may be used as UVA organic sunscreen in the composition are dibenzoylmethane compound, bisdisulizole disodium (commercially available as Neo Heliopan AP), diethylamino hydroxybenzoyl hexyl benzoate (commercially available as Uvinul A Plus), Ecamsule (commercially available as Mexoryl SX) and Methyl anthranilate.
Preferably, sunscreen that may be used as UVA organic sunscreen is selected from a dibenzoylmethane compound, diethylamino hydroxybenzoyl hexyl benzoate, and mixtures thereof.
More preferably, sunscreen that may be used as UVA organic sunscreen is selected from BMDM (commercially available as Parsol 1789 or Avobenzone),
a. 0.1 to 5 wt% UVA organic sunscreen, b. 0.1 to 10 wt% 2-ethylhexyl 2-cyano-3,3-diphenylacrylate, c. 0.1 to 2.5 wt% of a compound selected from resorcinol, phenylethyl resorcinol, 4-alkyl substituted resorcinol and mixtures thereof, d. 4 to 25 wt% fatty acid; and e. 0.1 to 10 wt% soap.
UVA organic sunscreen The composition according to the present invention (the composition) comprises UVA organic sunscreen that absorbs UVA radiations and prevents them from reaching a surface e.g. skin of a user.
Examples of sunscreens that may be used as UVA organic sunscreen in the composition are dibenzoylmethane compound, bisdisulizole disodium (commercially available as Neo Heliopan AP), diethylamino hydroxybenzoyl hexyl benzoate (commercially available as Uvinul A Plus), Ecamsule (commercially available as Mexoryl SX) and Methyl anthranilate.
Preferably, sunscreen that may be used as UVA organic sunscreen is selected from a dibenzoylmethane compound, diethylamino hydroxybenzoyl hexyl benzoate, and mixtures thereof.
More preferably, sunscreen that may be used as UVA organic sunscreen is selected from BMDM (commercially available as Parsol 1789 or Avobenzone),
6 2-methyldibenzoylmethane, 4-isopropyldibenzoyl-methane, 4-tert-butyldibenzoylmethane, 2,4-dimethyldibenzoylmethane, 2,5-dimethyldibenzoylmethane, 4,4'-diisopropyl-dibenzoylmethane, 2-methy1-5-isopropy1-4'-methoxydibenzoylmethane, 2-methy1-5-tert-buty1-4'-methoxy-dibenzoyl methane, 2,4-dimethy1-4'-methoxy dibenzoylmethane, 2,6-dimethy1-4-tert-buty1-4'-methoxy-dibenzoylmethane and mixtures thereof.
Most preferably, sunscreen that may be used as UVA organic sunscreen is BMDM.
The composition comprises 0.1 to 5 wt%, preferably 0.5 to 4.5 wt%, more preferably 1 to 4 wt%, even more preferably 1 to 3.5 wt%, further more preferably 1 to 3 wt%, still more preferably 1 to 2.5 wt% of one or more UVA
organic sunscreens.
2-ethylhexyl 2-cyano-3,3-diphenylacrylate (OCR) The composition comprises OCR (commercially available as OctocryleneTM) that absorbs UVB radiation and prevents them from reaching a surface e.g.
skin.
The composition comprises 0.1 to 10 wt%, preferably 0.5 to 9 wt%, more preferably 1 to 8 wt%, even more preferably 1.5 to 7 wt%, further more preferably 2 to 6 wt%, still more preferably 2.5 to 5 wt% and most preferably to 4 wt% OCR.
Resorcinol, phenylethyl resorcinol (PER), 4-alkyl substituted resorcinol The composition comprises a compound selected from resorcinol, PER, 4-alkyl substituted resorcinol and mixtures thereof. Such compounds are known to provide skin lightening effect.
Most preferably, sunscreen that may be used as UVA organic sunscreen is BMDM.
The composition comprises 0.1 to 5 wt%, preferably 0.5 to 4.5 wt%, more preferably 1 to 4 wt%, even more preferably 1 to 3.5 wt%, further more preferably 1 to 3 wt%, still more preferably 1 to 2.5 wt% of one or more UVA
organic sunscreens.
2-ethylhexyl 2-cyano-3,3-diphenylacrylate (OCR) The composition comprises OCR (commercially available as OctocryleneTM) that absorbs UVB radiation and prevents them from reaching a surface e.g.
skin.
The composition comprises 0.1 to 10 wt%, preferably 0.5 to 9 wt%, more preferably 1 to 8 wt%, even more preferably 1.5 to 7 wt%, further more preferably 2 to 6 wt%, still more preferably 2.5 to 5 wt% and most preferably to 4 wt% OCR.
Resorcinol, phenylethyl resorcinol (PER), 4-alkyl substituted resorcinol The composition comprises a compound selected from resorcinol, PER, 4-alkyl substituted resorcinol and mixtures thereof. Such compounds are known to provide skin lightening effect.
7 Preferably, the compound selected is 4-alkyl substituted resorcinol. The alkyl group in 4-alkyl substituted resorcinol can be straight chain alkyl or branched chain alkyl. For example, the alkyl group can be straight chain alkyl as in the case of 4-propyl resorcinol or it can be a branched chain alkyl like as in the case .. of 4-isopropyl resorcinol (IPR).
Examples of 4-alkyl substituted resorcinol include 4-methyl resorcinol, 4-ethyl resorcinol (ER), 4-propyl resorcinol, IPR, 4-butyl resorcinol (BR), 4-pentyl resorcinol, 4-hexyl resorcinol (HR), 4-heptyl resorcinol, 4-octyl resorcinol and mixtures thereof.
Preferred 4-alkyl substituted resorcinol are ER, BR, HR and mixtures thereof.
More preferred 4-alkyl substituted resorcinol are ER, HR and mixtures thereof.
.. It will be understood that the composition may comprise a combination of one or more compounds selected from resorcinol, PER and 4-alkyl substituted resorcinol. For example, the composition may comprise one or more 4-alkyl substituted resorcinol in presence or absence of resorcinol. Preferably, the composition comprises one compound selected from resorcinol, PER, 4-alkyl substituted resorcinol.
The composition comprises 0.1 to 2.5 wt%, preferably 0.1 to 2.25 wt%, more preferably 0.25 to 2 wt%, even more preferably 0.25 to 1.5 wt%, further more preferably 0.25 to 1 wt%, still more preferably 0.25 to 0.75 wt% and most preferably 0.25 to 0.5 wt% resorcinol, PER, 4-alkyl substituted resorcinol and mixtures thereof.
Fatty acid The composition comprises fatty acid. Fatty acids when present in a composition along with a soap provides the so called vanishing cream effect,
Examples of 4-alkyl substituted resorcinol include 4-methyl resorcinol, 4-ethyl resorcinol (ER), 4-propyl resorcinol, IPR, 4-butyl resorcinol (BR), 4-pentyl resorcinol, 4-hexyl resorcinol (HR), 4-heptyl resorcinol, 4-octyl resorcinol and mixtures thereof.
Preferred 4-alkyl substituted resorcinol are ER, BR, HR and mixtures thereof.
More preferred 4-alkyl substituted resorcinol are ER, HR and mixtures thereof.
.. It will be understood that the composition may comprise a combination of one or more compounds selected from resorcinol, PER and 4-alkyl substituted resorcinol. For example, the composition may comprise one or more 4-alkyl substituted resorcinol in presence or absence of resorcinol. Preferably, the composition comprises one compound selected from resorcinol, PER, 4-alkyl substituted resorcinol.
The composition comprises 0.1 to 2.5 wt%, preferably 0.1 to 2.25 wt%, more preferably 0.25 to 2 wt%, even more preferably 0.25 to 1.5 wt%, further more preferably 0.25 to 1 wt%, still more preferably 0.25 to 0.75 wt% and most preferably 0.25 to 0.5 wt% resorcinol, PER, 4-alkyl substituted resorcinol and mixtures thereof.
Fatty acid The composition comprises fatty acid. Fatty acids when present in a composition along with a soap provides the so called vanishing cream effect,
8 i.e. a composition, when applied on to the human skin, vanishes on the skin leaving behind no significant streaks of the composition.
The composition comprises fatty acids having carbon atoms preferably in the range 10 to 22, more preferably 12 to 22, even more preferably 14 to 22, further more preferably 16 to 22, yet more preferably from 18 to 22. It is found that a fatty acid with increasing chain length provides increasing UVAPF and/or increasing SPF.
.. Examples of fatty acids that may be used in the composition include lauric, myristic, palmitic, stearic, isostearic, oleic, linoleic, arachidic, behenic, erucic acid and mixtures thereof.
Alternatively, the fatty acid that may preferably be used is stearic acid or palmitic acid or a mixture thereof. The fatty acid in the present invention is preferably hystric acid which is substantially (generally about 90 to 95%) a mixture of stearic acid and palmitic acid in a ratio of between 55:45 to 45:55.
The composition comprises 4 to 25 wt%, preferably 6 to 22 wt%, more .. preferably 8 to 20 wt%, even more preferably 10 to 19 wt% and further more preferably 12 to 18 wt% fatty acid.
Soap The composition comprises soap. Soap when present in combination with fatty acid in the composition provides the so called vanishing effect.
Soap of the invention is generally prepared by in-situ neutralization of fatty acid present in the composition. Thus, it is preferred that the soap has a carbon chain length that corresponds to the chain length of fatty acid in the composition. The soap is formed from the fatty acid through use of alkali metal hydroxides e.g. sodium hydroxide or potassium hydroxide. Of the two,
The composition comprises fatty acids having carbon atoms preferably in the range 10 to 22, more preferably 12 to 22, even more preferably 14 to 22, further more preferably 16 to 22, yet more preferably from 18 to 22. It is found that a fatty acid with increasing chain length provides increasing UVAPF and/or increasing SPF.
.. Examples of fatty acids that may be used in the composition include lauric, myristic, palmitic, stearic, isostearic, oleic, linoleic, arachidic, behenic, erucic acid and mixtures thereof.
Alternatively, the fatty acid that may preferably be used is stearic acid or palmitic acid or a mixture thereof. The fatty acid in the present invention is preferably hystric acid which is substantially (generally about 90 to 95%) a mixture of stearic acid and palmitic acid in a ratio of between 55:45 to 45:55.
The composition comprises 4 to 25 wt%, preferably 6 to 22 wt%, more .. preferably 8 to 20 wt%, even more preferably 10 to 19 wt% and further more preferably 12 to 18 wt% fatty acid.
Soap The composition comprises soap. Soap when present in combination with fatty acid in the composition provides the so called vanishing effect.
Soap of the invention is generally prepared by in-situ neutralization of fatty acid present in the composition. Thus, it is preferred that the soap has a carbon chain length that corresponds to the chain length of fatty acid in the composition. The soap is formed from the fatty acid through use of alkali metal hydroxides e.g. sodium hydroxide or potassium hydroxide. Of the two,
9 potassium hydroxide is more preferred. Thus, the soap is preferably a potassium soap (potassium salt of fatty acid).
The composition comprises 0.1 to 10 wt%, preferably 1 to 8 wt%, more preferably 2 to 7 wt%, even more preferably 2 to 6 wt%, further more preferably 2 to 5 wt% and most preferably 2 to 4 wt% soap.
Preferably, the composition further comprises a nonionic surfactant having HLB
value in the range 9 to 20, preferably 10 to 19, more preferably 12 to 18, even more preferably 13 to 17 and yet more preferably 15 to 17.
HLB is calculated using the Griffin method wherein HLB = 20 x Mh / M wherein Mh is the molecular mass of the hydrophilic portion of the molecule and M is the molecular mass of the whole molecule, giving a result on an arbitrary scale of to 20. Typical values for various surfactants are given below:
A value <10 : Lipid soluble (water insoluble) A value >10: Water soluble A value from 4 to 8 indicates an anti-foaming agent A value from 7 to 11 indicates a W/O (water in oil) emulsifier A value from 12 to 16 indicates oil in water emulsifier A value from 11 to 14 indicates a wetting agent A value from 12 to 15 is typical of detergents A value of 16 to 20 indicates a solubiliser or a hydrotrope.
Preferably, the nonionic surfactant having HLB value in the range 9 to 20 is selected from fatty alcohol ethoxylates, alkyl phenol ethoxylates, polyoxyethylene sorbitan alkyl esters and mixtures thereof. Preferably, the nonionic surfactants are ones with at least 9 alkylene oxide groups preferably at least 9 ethylene oxide groups.
Examples of fatty alcohol ethoxylates that may be used as nonionic surfactants in the composition include polyoxyethylene lauryl ether (HLB= 16.9;
commercially available as Brij 35), polyoxyethylene (20) cetyl ether (HLB=16;
commercially available as Brij 58), polyethylene glycol octadecyl ether (HLB=
5 18.8; commercially available as Brij 700) and Laureth ¨9 (012E09;
HLB=14.3;
commercially available as Brij L9).
Examples of alkyl phenol ethoxylates that may be used as nonionic surfactant in the composition include octylphenol ethoxylate (HLB=15.5; commercially
The composition comprises 0.1 to 10 wt%, preferably 1 to 8 wt%, more preferably 2 to 7 wt%, even more preferably 2 to 6 wt%, further more preferably 2 to 5 wt% and most preferably 2 to 4 wt% soap.
Preferably, the composition further comprises a nonionic surfactant having HLB
value in the range 9 to 20, preferably 10 to 19, more preferably 12 to 18, even more preferably 13 to 17 and yet more preferably 15 to 17.
HLB is calculated using the Griffin method wherein HLB = 20 x Mh / M wherein Mh is the molecular mass of the hydrophilic portion of the molecule and M is the molecular mass of the whole molecule, giving a result on an arbitrary scale of to 20. Typical values for various surfactants are given below:
A value <10 : Lipid soluble (water insoluble) A value >10: Water soluble A value from 4 to 8 indicates an anti-foaming agent A value from 7 to 11 indicates a W/O (water in oil) emulsifier A value from 12 to 16 indicates oil in water emulsifier A value from 11 to 14 indicates a wetting agent A value from 12 to 15 is typical of detergents A value of 16 to 20 indicates a solubiliser or a hydrotrope.
Preferably, the nonionic surfactant having HLB value in the range 9 to 20 is selected from fatty alcohol ethoxylates, alkyl phenol ethoxylates, polyoxyethylene sorbitan alkyl esters and mixtures thereof. Preferably, the nonionic surfactants are ones with at least 9 alkylene oxide groups preferably at least 9 ethylene oxide groups.
Examples of fatty alcohol ethoxylates that may be used as nonionic surfactants in the composition include polyoxyethylene lauryl ether (HLB= 16.9;
commercially available as Brij 35), polyoxyethylene (20) cetyl ether (HLB=16;
commercially available as Brij 58), polyethylene glycol octadecyl ether (HLB=
5 18.8; commercially available as Brij 700) and Laureth ¨9 (012E09;
HLB=14.3;
commercially available as Brij L9).
Examples of alkyl phenol ethoxylates that may be used as nonionic surfactant in the composition include octylphenol ethoxylate (HLB=15.5; commercially
10 available as TritonTm X165), octylphenol ethoxylate (HLB=17.6;
commercially available as TritonTm X405) and octylphenol ethoxylate (HLB=18.4;
commercially available as Triton TM X705).
Examples of polyoxyethylene sorbitan alkyl esters that may be used as the nonionic surfactant in the composition include polyoxyethylenesorbitan monolaurate (HLB=13.3; commercially available as Tween 21), polyoxyethylenesorbitan monolaurate (HLB=16.7; commercially available as Tween 20), Polyoxyethylenesorbitan monopalmitate (HLB=15.6; commercially available as Tween 40) and polyoxyethylene sorbitan monostearate (HLB=
14.9; commercially available as Tween 60).
More preferably, the nonionic surfactant having HLB value in the range 9 to 20 that may be present in the composition is fatty alcohol ethoxylate with saturated carbon chain having HLB higher than 15.5.
Preferably, the composition comprises 0.5 to 5 wt%, more preferably 1 to 4 wt%, even more preferably from 2 to 3 wt% nonionic surfactant having HLB in the range 9 to 20.
commercially available as TritonTm X405) and octylphenol ethoxylate (HLB=18.4;
commercially available as Triton TM X705).
Examples of polyoxyethylene sorbitan alkyl esters that may be used as the nonionic surfactant in the composition include polyoxyethylenesorbitan monolaurate (HLB=13.3; commercially available as Tween 21), polyoxyethylenesorbitan monolaurate (HLB=16.7; commercially available as Tween 20), Polyoxyethylenesorbitan monopalmitate (HLB=15.6; commercially available as Tween 40) and polyoxyethylene sorbitan monostearate (HLB=
14.9; commercially available as Tween 60).
More preferably, the nonionic surfactant having HLB value in the range 9 to 20 that may be present in the composition is fatty alcohol ethoxylate with saturated carbon chain having HLB higher than 15.5.
Preferably, the composition comprises 0.5 to 5 wt%, more preferably 1 to 4 wt%, even more preferably from 2 to 3 wt% nonionic surfactant having HLB in the range 9 to 20.
11 Preferably, the composition further comprises a polymer. The polymer acts as thickener in the composition and improves sensorial properties of the composition.
The polymer is preferably selected from the following classes:
- acrylate / R-methacrylate copolymer e.g. acrylates/ steareth-20 methacrylate copolymer (commercially available as AculynTM 22) and acrylates/ beheneth-25 methacrylate copolymer (commercially available as Aculyn TM 28), - acrylate / R-methacrylate crosspolymer e.g. acrylates/steareth-20 methacrylate crosspolymer (commercially available as AculynTM 88), - acrylates copolymer (commercially available as AculynTM 33), - acrylate/R-alkyl acrylate crosspolymer e.g. acrylates/C10-030 alkyl acrylate crosspolymer (commercially available as PemulenTM TR-2), - copolymer of ammonium acryloyldimethyltaurate with vinyl pyrrolidone (commercially available as Aristoflex AVC), - copolymer of sodium acryloyldimethyltaurate with vinyl pyrrolidone (commercially available as Aristoflex AVS); and - crosspolymer of acryloyldimethyltaurate with R-alkyl acrylate and methyacrylate e.g. Ammonium acryloyldimethyltaurate/ beheneth-25 methacrylate crosspolymer (commercially available as Aristoflex HMB
and Aristoflex BLV); and mixtures thereof.
More preferably, the polymer is selected from acrylate / R-methacrylate copolymer, acrylates copolymer and mixtures thereof.
Preferably, the composition comprises 0.1 to 5 wt%, more preferably 0.5 to 4.5 wt%, even more preferably 1 to 4 wt%, further more preferably from 1.5 to 3.5 wt%, still more preferably from 2 to 3 wt% polymer.
The polymer is preferably selected from the following classes:
- acrylate / R-methacrylate copolymer e.g. acrylates/ steareth-20 methacrylate copolymer (commercially available as AculynTM 22) and acrylates/ beheneth-25 methacrylate copolymer (commercially available as Aculyn TM 28), - acrylate / R-methacrylate crosspolymer e.g. acrylates/steareth-20 methacrylate crosspolymer (commercially available as AculynTM 88), - acrylates copolymer (commercially available as AculynTM 33), - acrylate/R-alkyl acrylate crosspolymer e.g. acrylates/C10-030 alkyl acrylate crosspolymer (commercially available as PemulenTM TR-2), - copolymer of ammonium acryloyldimethyltaurate with vinyl pyrrolidone (commercially available as Aristoflex AVC), - copolymer of sodium acryloyldimethyltaurate with vinyl pyrrolidone (commercially available as Aristoflex AVS); and - crosspolymer of acryloyldimethyltaurate with R-alkyl acrylate and methyacrylate e.g. Ammonium acryloyldimethyltaurate/ beheneth-25 methacrylate crosspolymer (commercially available as Aristoflex HMB
and Aristoflex BLV); and mixtures thereof.
More preferably, the polymer is selected from acrylate / R-methacrylate copolymer, acrylates copolymer and mixtures thereof.
Preferably, the composition comprises 0.1 to 5 wt%, more preferably 0.5 to 4.5 wt%, even more preferably 1 to 4 wt%, further more preferably from 1.5 to 3.5 wt%, still more preferably from 2 to 3 wt% polymer.
12 Preferably, the composition comprises a cosmetically acceptable vehicle that includes water and may be present in the composition in amount 5 to 99.9 wt%, preferably 10 to 95 wt%, more preferably 15 to 90 wt%, even more preferably 20 to 80 wt%, further more preferably 25 to 75 wt% and still more preferably 30 to 70 wt%.
Preferably, the composition further comprises one or more skin lightening agents. These one or more skin lightening agents may be selected from niacinamide, vitamin B6, vitamin C, vitamin A, glutathione precursors, galardin, adapalene, aloe extract, ammonium lactate, arbutin, azelaic acid, butyl hydroxy anisole, butyl hydroxy toluene, citrate esters, deoxyarbutin, 1,3-diphenyl propane derivatives, 2,5-dihydroxybenzoic acid and its derivatives, 2-(4-acetoxypheny1)-1,3-dithiane, 2-(4-hydroxypheny1)-1,3-dithiane, ellagic acid, gluco pyranosy1-1-ascorbate, gluconic acid, glycolic acid, green tea extract, Hydroxy-5-methyl-3[2H]uranone, 4-hydroxyanisole and its derivatives, 4-hydroxybenzoic acid derivatives, hydroxycaprylic acid, inositol ascorbate, lactic acid, lemon extract, linoleic acid, magnesium ascorbyl phosphate, 5-octanoyl salicylic acid, salicylic acid, 3,4,5-trihydroxybenzyl derivatives, acetylglucosamine, pitera extract, symwhite, calcium pantothenate (Melano-block), seppiwhite, soybean extract (bowman birk inhibitor), 12-hydroxystearic acid and mixtures thereof. When used in the composition, 12-hydroxystearic acid is used as a skin lightening agent and not as a fatty acid.
Preferably, skin lightening agents that may be used in the composition are niacinamide, vitamin B6, 12-hydroxystearic acid, glutathione precursors, galardin and mixtures thereof.
When incorporated in the composition, a skin lightening agent may be added in an amount 0.001 to 15 wt%, preferably 0.01 to 10 wt%, more preferably 0.1 to 5 wt%, even more preferably 0.5 to 3 wt%, in the composition.
Preferably, the composition further comprises one or more skin lightening agents. These one or more skin lightening agents may be selected from niacinamide, vitamin B6, vitamin C, vitamin A, glutathione precursors, galardin, adapalene, aloe extract, ammonium lactate, arbutin, azelaic acid, butyl hydroxy anisole, butyl hydroxy toluene, citrate esters, deoxyarbutin, 1,3-diphenyl propane derivatives, 2,5-dihydroxybenzoic acid and its derivatives, 2-(4-acetoxypheny1)-1,3-dithiane, 2-(4-hydroxypheny1)-1,3-dithiane, ellagic acid, gluco pyranosy1-1-ascorbate, gluconic acid, glycolic acid, green tea extract, Hydroxy-5-methyl-3[2H]uranone, 4-hydroxyanisole and its derivatives, 4-hydroxybenzoic acid derivatives, hydroxycaprylic acid, inositol ascorbate, lactic acid, lemon extract, linoleic acid, magnesium ascorbyl phosphate, 5-octanoyl salicylic acid, salicylic acid, 3,4,5-trihydroxybenzyl derivatives, acetylglucosamine, pitera extract, symwhite, calcium pantothenate (Melano-block), seppiwhite, soybean extract (bowman birk inhibitor), 12-hydroxystearic acid and mixtures thereof. When used in the composition, 12-hydroxystearic acid is used as a skin lightening agent and not as a fatty acid.
Preferably, skin lightening agents that may be used in the composition are niacinamide, vitamin B6, 12-hydroxystearic acid, glutathione precursors, galardin and mixtures thereof.
When incorporated in the composition, a skin lightening agent may be added in an amount 0.001 to 15 wt%, preferably 0.01 to 10 wt%, more preferably 0.1 to 5 wt%, even more preferably 0.5 to 3 wt%, in the composition.
13 Preferably, the composition further comprises emollients. Examples of emollients that may be used in the composition include stearyl alcohol, glyceryl monoricinoleate, mink oil, cetyl alcohol, isopropyl isostearate, isobutyl palmitate, isocetyl stearate, oleyl alcohol, isopropyl laurate, hexyl laurate, decyl oleate, octadecan-2-ol, isocetyl alcohol, eicosanyl alcohol, behenyl alcohol, cetyl palmitate, silicone oils such as dimethylpolysiloxane, din-butyl sebacate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, butyl stearate, polyethylene glycol, triethylene glycol, lanolin, cocoa butter, corn oil, cotton seed oil, olive oil, palm kernel oil, rape seed oil, safflower seed oil, evening primrose oil, soybean oil, sunflower seed oil, avocado oil, sesame seed oil, coconut oil, arachis oil, castor oil, acetylated lanolin alcohols, petroleum jelly, mineral oil, butyl myristate, isopropyl linoleate, lauryl lactate, myristyl lactate, decyl oleate, myristyl myristate and mixtures thereof.
Preferably, the composition further comprises solvents. Examples of solvents that may be used in the composition include ethyl alcohol, isopropanol, acetone, ethylene glycol monoethyl ether, diethylene glycol monobutyl ether, diethylene glycol monoethyl ether and mixtures thereof.
Preferably, the composition further comprises powders. Examples of powders that may be used in the composition include chalk, talc, fullers earth, kaolin, starch, gums, colloidal silica sodium polyacrylate, tetra alkyl and/or trialkyl aryl ammonium smectites, chemically modified magnesium aluminium silicate, organically modified montmorillonite clay, hydrated aluminium silicate, fumed silica, carboxyvinyl polymer, sodium carboxymethyl cellulose, ethylene glycol monostearate and mixtures thereof.
Preferably, the composition further comprises preservatives to protect against the growth of potentially harmful microorganisms. Examples of ingredients that may be used as preservatives in the composition include alkyl esters of para-hydroxybenzoic acid, hydantoin derivatives, propionate salts, and a variety
Preferably, the composition further comprises solvents. Examples of solvents that may be used in the composition include ethyl alcohol, isopropanol, acetone, ethylene glycol monoethyl ether, diethylene glycol monobutyl ether, diethylene glycol monoethyl ether and mixtures thereof.
Preferably, the composition further comprises powders. Examples of powders that may be used in the composition include chalk, talc, fullers earth, kaolin, starch, gums, colloidal silica sodium polyacrylate, tetra alkyl and/or trialkyl aryl ammonium smectites, chemically modified magnesium aluminium silicate, organically modified montmorillonite clay, hydrated aluminium silicate, fumed silica, carboxyvinyl polymer, sodium carboxymethyl cellulose, ethylene glycol monostearate and mixtures thereof.
Preferably, the composition further comprises preservatives to protect against the growth of potentially harmful microorganisms. Examples of ingredients that may be used as preservatives in the composition include alkyl esters of para-hydroxybenzoic acid, hydantoin derivatives, propionate salts, and a variety
14 PCT/EP2019/059662 of quaternary ammonium compounds. More preferably, ingredients that may be used as preservative in the composition are sodium benzoate, iodopropynyl butyl carbamate, methylisothiazolinone, iodopropynylbutylcarbamate, phenoxyethanol, methyl paraben, propyl paraben, imidazolidinyl urea, sodium dehydroacetate, ethylhexylglycerin, benzyl alcohol, alkane diols and mixtures thereof. The alkane diols that are suitable for use as preservative are 06-012 al kanes that are vicinally substituted with hydroxy groups. Illustrative examples include 1,2-octane diol (caprylyl glycol), 2,3-octane diol, 1,2-nonane diol, 1,2-decane diol, 1,2-hexane diol, 3,4-octane diol, mixtures thereof or the like where caprylyl glycol is typically the most preferred.
When present in the composition, preservatives are added preferably in an amount 0.001 to 5 wt%, more preferably 0.01 to 3 wt% and most preferably 0.02 to 2 wt%.
The composition may further comprise a range of other optional ingredients that include antioxidants, binders, biological additives, buffering agents, colorants, astringents, fragrance, opacifying agents, conditioners, exfoliating agents, pH
adjusters, skin soothing agents, and skin healing agents.
The composition is preferably formulated in the form of a powder, flake, lotion, cream, gel or mousse. More preferably, the composition is formulated in the form of cream or lotion and most preferably in the form of cream. The composition can be a leave-on or wash-off type of composition. The composition is preferably a leave-on type of composition. The packaging for the composition of this invention can be a patch, bottle, tube, roll-ball applicator, propellant driven aerosol device, squeeze container or lidded jar.
It is found that a resorcinol, phenylethyl resorcinol, 4-alkyl substituted resorcinol and mixtures thereof improve the UVAPF when present in the composition according to the first aspect. It is also found that such improved UVAPF is obtained only when OCR was used in presence of UVA organic sunscreen. An improved UVAPF was not obtained when other UVB organic sunscreen e.g.
MCX was used instead of OCR. OCR is known to stabilize dibenzoylmethane compound, e.g. BMDM. It is found that improvement in UVAPF obtained in 5 presence of a compound selected from resorcinol, phenylethyl resorcinol, alkyl substituted resorcinol and mixtures thereof, is over and above the UVAPF
obtained when OCR is used instead of MCX in the same composition. Thus, it is surprising that replacing one UVB sunscreen, i.e. MCX, with another UVB
sunscreen, i.e. OCR, has surprisingly resulted in improved UVAPF where 10 delivering UVAPF is a function of UVA sunscreen.
Preferably, the sunscreen composition is a composition comprising:
a. 0.1 to 5 wt% dibenzoylmethane compound, b. 0.1 to 10 wt% 2-ethylhexyl 2-cyano-3,3-diphenylacrylate,
When present in the composition, preservatives are added preferably in an amount 0.001 to 5 wt%, more preferably 0.01 to 3 wt% and most preferably 0.02 to 2 wt%.
The composition may further comprise a range of other optional ingredients that include antioxidants, binders, biological additives, buffering agents, colorants, astringents, fragrance, opacifying agents, conditioners, exfoliating agents, pH
adjusters, skin soothing agents, and skin healing agents.
The composition is preferably formulated in the form of a powder, flake, lotion, cream, gel or mousse. More preferably, the composition is formulated in the form of cream or lotion and most preferably in the form of cream. The composition can be a leave-on or wash-off type of composition. The composition is preferably a leave-on type of composition. The packaging for the composition of this invention can be a patch, bottle, tube, roll-ball applicator, propellant driven aerosol device, squeeze container or lidded jar.
It is found that a resorcinol, phenylethyl resorcinol, 4-alkyl substituted resorcinol and mixtures thereof improve the UVAPF when present in the composition according to the first aspect. It is also found that such improved UVAPF is obtained only when OCR was used in presence of UVA organic sunscreen. An improved UVAPF was not obtained when other UVB organic sunscreen e.g.
MCX was used instead of OCR. OCR is known to stabilize dibenzoylmethane compound, e.g. BMDM. It is found that improvement in UVAPF obtained in 5 presence of a compound selected from resorcinol, phenylethyl resorcinol, alkyl substituted resorcinol and mixtures thereof, is over and above the UVAPF
obtained when OCR is used instead of MCX in the same composition. Thus, it is surprising that replacing one UVB sunscreen, i.e. MCX, with another UVB
sunscreen, i.e. OCR, has surprisingly resulted in improved UVAPF where 10 delivering UVAPF is a function of UVA sunscreen.
Preferably, the sunscreen composition is a composition comprising:
a. 0.1 to 5 wt% dibenzoylmethane compound, b. 0.1 to 10 wt% 2-ethylhexyl 2-cyano-3,3-diphenylacrylate,
15 c. 0.1 to 2.5 wt% a compound selected from BR, ER, HR and mixtures thereof, d. 4 to 25 wt% fatty acid; and e. 0.1 to 10 wt% soap.
More preferably, the sunscreen composition is a composition comprising:
a. 0.1 to 5 wt% 4-tert-butyl-4'-methoxydibenzoylmethane, b. 0.1 to 10 wt% 2-ethylhexyl 2-cyano-3,3-diphenylacrylate, c. 0.1 to 2.5 wt% a compound selected from ER, HR and mixtures thereof, d. 4 to 25 wt% fatty acid; and e. 0.1 to 10 wt% soap.
In a second aspect, the present invention further relates to a method of providing improved UVAPF, wherein the method comprises the step of:
a. applying on to the skin a sunscreen composition of the first aspect; and
More preferably, the sunscreen composition is a composition comprising:
a. 0.1 to 5 wt% 4-tert-butyl-4'-methoxydibenzoylmethane, b. 0.1 to 10 wt% 2-ethylhexyl 2-cyano-3,3-diphenylacrylate, c. 0.1 to 2.5 wt% a compound selected from ER, HR and mixtures thereof, d. 4 to 25 wt% fatty acid; and e. 0.1 to 10 wt% soap.
In a second aspect, the present invention further relates to a method of providing improved UVAPF, wherein the method comprises the step of:
a. applying on to the skin a sunscreen composition of the first aspect; and
16 b. optionally, rinsing with water.
The present invention also provides a method of providing improved UVAPF
comprising the steps of applying the composition of the first aspect on to a surface e.g. skin, in case of a leave-on composition. This method optionally comprises an additional step of at least partially removing the composition from the surface if it is in the form of a wash-off composition. Preferably, the method is non-therapeutic or cosmetic. When the composition is applied on to the skin, an improved UVAPF is obtained.
In a third aspect, the present invention relates to use of the composition of the first aspect for improved UVAPF.
The present invention now will be demonstrated by way of following non-limiting examples.
Examples Protocols Preparation of composition Briefly, the composition as per the present invention was prepared as follows:
Demineralised water and potassium hydroxide were charged in a beaker (main beaker) mounted on a magnetic stirrer and heater. The water phase was heated to 75 C and maintained at the same temperature. In a side pot, a fatty acid mentioned in examples below was heated to 75 C for melting and was added to .. the main beaker maintained at 75 C. The system was stirred for 5 minutes at 75 C. The sunscreens as mentioned in examples, other oil soluble ingredients and nonionic surfactant were taken in a separate beaker and heated to 65 to 70 C for melting. They were mixed well and were added to the main beaker.
Stirring was continued for another 5 minutes at 75 C. The stirrer and heater were switched off and mixing was done manually until temperature reached ambient (25 C).
The present invention also provides a method of providing improved UVAPF
comprising the steps of applying the composition of the first aspect on to a surface e.g. skin, in case of a leave-on composition. This method optionally comprises an additional step of at least partially removing the composition from the surface if it is in the form of a wash-off composition. Preferably, the method is non-therapeutic or cosmetic. When the composition is applied on to the skin, an improved UVAPF is obtained.
In a third aspect, the present invention relates to use of the composition of the first aspect for improved UVAPF.
The present invention now will be demonstrated by way of following non-limiting examples.
Examples Protocols Preparation of composition Briefly, the composition as per the present invention was prepared as follows:
Demineralised water and potassium hydroxide were charged in a beaker (main beaker) mounted on a magnetic stirrer and heater. The water phase was heated to 75 C and maintained at the same temperature. In a side pot, a fatty acid mentioned in examples below was heated to 75 C for melting and was added to .. the main beaker maintained at 75 C. The system was stirred for 5 minutes at 75 C. The sunscreens as mentioned in examples, other oil soluble ingredients and nonionic surfactant were taken in a separate beaker and heated to 65 to 70 C for melting. They were mixed well and were added to the main beaker.
Stirring was continued for another 5 minutes at 75 C. The stirrer and heater were switched off and mixing was done manually until temperature reached ambient (25 C).
17 Measurement of In-vitro SPF / UVA-PF
Thin film transmittance measurements were done using SPF-290S SPF meter (Optometrics Corporation). In this study, 70 x 70 mm PMMA plate with 6 pm roughness from Schonberg GmbH & Co were used. The percent transmittance .. of the various compositions was measured as follows. 2 mg/cm2 of a test sample was applied on PMMA plate, distributed uniformly using a syringe, and spread uniformly. The drying time for the PMMA plates was 30 minutes. After the drying time, sample plates were exposed to UV light and transmittance scan was recorded. This scan gives the transmittance as a function of wavelength (290 to 400 nm) for a given sample. For a single plate, six to eight different spots were scanned. The same was repeated for 3 plates. The data reported is thus an average over 18 readings. The reference transmittance scan was obtained using a blank plate, with no sample on the PMMA plates with glycerin spread on it. The transmittance values were used to arrive at the SPF values using the Win SPF software provided with the instrument. The transmittance values used to calculate the UVAPF values for each composition.
In-vivo SPF/UVAPF
The compositions outlined in examples shown in Table 1 were tested in a randomized human volunteer study carried out with appropriate controls.
Briefly, minimum erythemal dose (MED) and minimal persistent pigment darkening dose (MPPDD) for each volunteer was estimated before sample (compositions in table 1) application. The test samples were blinded with the standard samples for which the SPF/UVAPF is known. The required amount of sample (2 .. mg/cm2) was applied on the back skin of volunteers. The samples were dispensed uniformly using a syringe and applied uniformly using a finger cot over a period of 20 to 50 seconds which depends on the ease of application of a composition. For each sample new finger cot is used. Post sample application, the subjects were exposed to UV, dosage of which is calculated based on MED
and MPPDD (specific to each volunteer) and on the anticipated or target SPF/UVAPF. Post exposure, volunteers were evaluated for the erythema and
Thin film transmittance measurements were done using SPF-290S SPF meter (Optometrics Corporation). In this study, 70 x 70 mm PMMA plate with 6 pm roughness from Schonberg GmbH & Co were used. The percent transmittance .. of the various compositions was measured as follows. 2 mg/cm2 of a test sample was applied on PMMA plate, distributed uniformly using a syringe, and spread uniformly. The drying time for the PMMA plates was 30 minutes. After the drying time, sample plates were exposed to UV light and transmittance scan was recorded. This scan gives the transmittance as a function of wavelength (290 to 400 nm) for a given sample. For a single plate, six to eight different spots were scanned. The same was repeated for 3 plates. The data reported is thus an average over 18 readings. The reference transmittance scan was obtained using a blank plate, with no sample on the PMMA plates with glycerin spread on it. The transmittance values were used to arrive at the SPF values using the Win SPF software provided with the instrument. The transmittance values used to calculate the UVAPF values for each composition.
In-vivo SPF/UVAPF
The compositions outlined in examples shown in Table 1 were tested in a randomized human volunteer study carried out with appropriate controls.
Briefly, minimum erythemal dose (MED) and minimal persistent pigment darkening dose (MPPDD) for each volunteer was estimated before sample (compositions in table 1) application. The test samples were blinded with the standard samples for which the SPF/UVAPF is known. The required amount of sample (2 .. mg/cm2) was applied on the back skin of volunteers. The samples were dispensed uniformly using a syringe and applied uniformly using a finger cot over a period of 20 to 50 seconds which depends on the ease of application of a composition. For each sample new finger cot is used. Post sample application, the subjects were exposed to UV, dosage of which is calculated based on MED
and MPPDD (specific to each volunteer) and on the anticipated or target SPF/UVAPF. Post exposure, volunteers were evaluated for the erythema and
18 MPPDD. An evaluation of the SPF of was carried out using ISO Standard 24444: 2010. An evaluation of UVAPF was carried out using ISO 24442:2011.
The data reported here is an average of 5 volunteers.
Table 1 Ingredients 1 2 A B C
Soap 2.62 2.62 2.62 2.62 2.62 (formed in-situ) Hystric acid 17 17 17 17 17 Nonionic surfactant (Brij 35) UVA Sunscreen 1.2 1.2 1.2 1.2 1.2 (BMDM) 2-ethylhexyl 2-cyano-3,3-diphenylacrylate 3 3 3 - -(OCR) MCX - - - 2.4 2.4 HR 0.5 0.25 - - 0.5 Polymer (Aculyn 22) Polymer 0.5 0.5 0.5 0.5 0.5 (Aculyn A33) In-vivo UVAPF 14 17 13 7 7 The data in table 1 shows that improved UVAPF is obtained using compositions as per the present invention (examples 1 and 2) that comprises HR along with BMDM, OCR, fatty acid and soap as compared to the comparative examples (example A and B; not as per the present invention) that do not contain HR.
The data reported here is an average of 5 volunteers.
Table 1 Ingredients 1 2 A B C
Soap 2.62 2.62 2.62 2.62 2.62 (formed in-situ) Hystric acid 17 17 17 17 17 Nonionic surfactant (Brij 35) UVA Sunscreen 1.2 1.2 1.2 1.2 1.2 (BMDM) 2-ethylhexyl 2-cyano-3,3-diphenylacrylate 3 3 3 - -(OCR) MCX - - - 2.4 2.4 HR 0.5 0.25 - - 0.5 Polymer (Aculyn 22) Polymer 0.5 0.5 0.5 0.5 0.5 (Aculyn A33) In-vivo UVAPF 14 17 13 7 7 The data in table 1 shows that improved UVAPF is obtained using compositions as per the present invention (examples 1 and 2) that comprises HR along with BMDM, OCR, fatty acid and soap as compared to the comparative examples (example A and B; not as per the present invention) that do not contain HR.
19 Further, the data also shows that improved UVAPF is obtained only when a select UVB sunscreen, i.e. OCR (example 1), is used instead of MCX (example C) despite that both these compositions comprise the same amount, i.e. 0.5 wt%, of HR. Thus, HR provided improved UVAPF when used in combination with UVA organic sunscreen, 2-ethylhexyl 2-cyano-3,3-diphenylacrylate, fatty acid and soap. This improved UVAPF was not obtained when MCX was present instead of OCR.
The data in table 1 also shows that absence or presence of HR in the compositions of example B and C has no effect on UVAPF.
Surprisingly, it was found that improvement in UVAPF was not dependent on dose of HR used. As seen from example 2 (0.25 wt% HR), UVAPF equal to 17 was obtained whereas example 1 (0.5 wt% HR) showed UVAPF equal to 14. It is believed that such an effect is due to superoxide quenching efficacy which was found to increase with increasing concentration of HR up to a concentration (2 mM). Thereafter, superoxide quenching efficacy decreased despite increase in concentration of HR under uniform light exposure conditions.
Effect of amount of soap in the composition on UVAPF and SPF
The compositions outlined in table 2 demonstrate the effect of presence of soap in the composition as compared to the control (no soap).
Table 2 Ingredients D 3 4 5 Soap 0 2.62 5 7.5 (formed in-situ) Hystric acid 17 17 17 17 Nonionic 2 2 2 2 surfactant (Brij 35) UVA Sunscreen 1.2 1.2 1.2 1.2 BMDM
OCR 3.0 3.0 3.0 3.0 MCX - - - -HR 0.25 0.25 0.25 0.25 Polymer 1 1 1 1 (Aculyn 22) Polymer 0.5 0.5 0.5 0.5 (Aculyn 33) In-vitro SPF 9.52 0.78 22.04 3.04 16.96 1.58 15.75 0.95 In-vitro UVAPF 6.87 0.37 10.63 0.83 9.28 0.57 9.03 0.40 The data in table 2 shows that soap, when present in the composition as per the present invention, boosts SPF as well as UVAPF.
5 Further, additional compositions as shown in table 3 below were prepared as described earlier and UVAPF and SPF were measured as described earlier.
The results found were as provided in table 3 below.
Table 3 Ingredients 6 7 8 9 Soap 2.5 2.75 2.62 2.62 (formed in-situ) Polymer 0.5 0.5 0.5 0.5 (Aculyn 33) Nonionic surfactant 2 2 2 2 (Brij 35) Palmitic acid 17 - - -Stearic acid - 17 - -Hystric Acid - - 17 17 BMDM 1.2 1.2 1.2 1.2 HR 0.25 0.25 - -BR - - 0.25 -ER - - - 0.25 UVAPF
14.7 0.8 17.98 0.81 13.84 0.31 13.5 0.89 (in-vitro) SPF
22.47 0.8 27.09 1.93 27.44 0.97 25.4 1.09 (in-vitro) The data in table 3 shows that an enhanced UVAPF is obtained when palmitic acid as shown in example 6; or stearic acid as shown in example 7, were used in the composition.
The data in table 3 also shows that an enhanced UVAPF is obtained when BR
as shown in example 8; or ER as shown in example 9, were used in the composition.
In conclusion, the sunscreen compositions as per the present invention provide an improved UVAPF.
The data in table 1 also shows that absence or presence of HR in the compositions of example B and C has no effect on UVAPF.
Surprisingly, it was found that improvement in UVAPF was not dependent on dose of HR used. As seen from example 2 (0.25 wt% HR), UVAPF equal to 17 was obtained whereas example 1 (0.5 wt% HR) showed UVAPF equal to 14. It is believed that such an effect is due to superoxide quenching efficacy which was found to increase with increasing concentration of HR up to a concentration (2 mM). Thereafter, superoxide quenching efficacy decreased despite increase in concentration of HR under uniform light exposure conditions.
Effect of amount of soap in the composition on UVAPF and SPF
The compositions outlined in table 2 demonstrate the effect of presence of soap in the composition as compared to the control (no soap).
Table 2 Ingredients D 3 4 5 Soap 0 2.62 5 7.5 (formed in-situ) Hystric acid 17 17 17 17 Nonionic 2 2 2 2 surfactant (Brij 35) UVA Sunscreen 1.2 1.2 1.2 1.2 BMDM
OCR 3.0 3.0 3.0 3.0 MCX - - - -HR 0.25 0.25 0.25 0.25 Polymer 1 1 1 1 (Aculyn 22) Polymer 0.5 0.5 0.5 0.5 (Aculyn 33) In-vitro SPF 9.52 0.78 22.04 3.04 16.96 1.58 15.75 0.95 In-vitro UVAPF 6.87 0.37 10.63 0.83 9.28 0.57 9.03 0.40 The data in table 2 shows that soap, when present in the composition as per the present invention, boosts SPF as well as UVAPF.
5 Further, additional compositions as shown in table 3 below were prepared as described earlier and UVAPF and SPF were measured as described earlier.
The results found were as provided in table 3 below.
Table 3 Ingredients 6 7 8 9 Soap 2.5 2.75 2.62 2.62 (formed in-situ) Polymer 0.5 0.5 0.5 0.5 (Aculyn 33) Nonionic surfactant 2 2 2 2 (Brij 35) Palmitic acid 17 - - -Stearic acid - 17 - -Hystric Acid - - 17 17 BMDM 1.2 1.2 1.2 1.2 HR 0.25 0.25 - -BR - - 0.25 -ER - - - 0.25 UVAPF
14.7 0.8 17.98 0.81 13.84 0.31 13.5 0.89 (in-vitro) SPF
22.47 0.8 27.09 1.93 27.44 0.97 25.4 1.09 (in-vitro) The data in table 3 shows that an enhanced UVAPF is obtained when palmitic acid as shown in example 6; or stearic acid as shown in example 7, were used in the composition.
The data in table 3 also shows that an enhanced UVAPF is obtained when BR
as shown in example 8; or ER as shown in example 9, were used in the composition.
In conclusion, the sunscreen compositions as per the present invention provide an improved UVAPF.
Claims (15)
1. A sunscreen composition comprising:
a. 0.1 to 5 wt% UVA organic sunscreen, b. 0.1 to 10 wt% 2-ethylhexyl 2-cyano-3,3-diphenylacrylate, c. 0.1 to 2.5 wt% of a compound selected from resorcinol, phenylethyl resorcinol, 4-alkyl substituted resorcinol and mixtures thereof, d. 4 to 25 wt% fatty acid; and e. 0.1 to 10 wt% soap.
a. 0.1 to 5 wt% UVA organic sunscreen, b. 0.1 to 10 wt% 2-ethylhexyl 2-cyano-3,3-diphenylacrylate, c. 0.1 to 2.5 wt% of a compound selected from resorcinol, phenylethyl resorcinol, 4-alkyl substituted resorcinol and mixtures thereof, d. 4 to 25 wt% fatty acid; and e. 0.1 to 10 wt% soap.
2. The sunscreen composition according to claim 1 further comprising a nonionic surfactant having HLB value in the range 9 to 20.
3. The sunscreen composition according to claims 1 or 2 wherein the nonionic surfactant is fatty alcohol ethoxylate with saturated carbon chain having HLB in the range 15.5 to 20.
4. The sunscreen composition according to any one of claims 1 to 3 further comprising 0.1 to 5 wt% of a polymer.
5. The sunscreen composition according to any one of claims 1 to 4 comprising 0.1 to 3 wt% soap.
6. The sunscreen composition according to any one of claims 1 to 5 comprising 8 to 20 wt% fatty acid.
7. The sunscreen composition according to any one of claims 1 to 6 wherein 4-alkyl-substituted resorcinol is selected from 4-methyl resorcinol, 4-ethyl resorcinol, 4-propyl resorcinol, 4-isopropyl resorcinol, 4-butyl resorcinol, 4-pentyl resorcinol, 4-hexyl resorcinol, 4-heptyl resorcinol, 4-octyl resorcinol and mixtures thereof.
8. The sunscreen composition according to any one of claims 1 to 7 wherein 4-alkyl-substituted resorcinol is selected from 4-ethyl resorcinol, 4-hexyl resorcinol and mixtures thereof.
9. The sunscreen composition as per any one of claims 1 to 8 further comprising 0.001 to 15 wt% of a skin lightening agent.
10.The sunscreen composition as per any one of claims 1 to 9, wherein the UVA sunscreen is selected from 4-tert-butyl-4'-methoxydibenzoylmethane, 2-methyldibenzoylmethane, 4-isopropyldibenzoyl-methane, 4-tert-butyldibenzoylmethane, 2,4-dimethyldibenzoylmethane, 2,5-dimethyldibenzoylmethane, 4,4'-diisopropyl-dibenzoylmethane, 2-methyl-5-isopropyl-4'-methoxydibenzoylmethane, 2-methyl-5-tert-butyl-4'-methoxy-dibenzoyl methane, 2,4-dimethyl-4'-methoxy dibenzoylmethane or 2,6-dimethyl-4-tert-butyl-4'-methoxy-dibenzoylmethane.
11.The sunscreen composition as per any one of claims 1 to 10, wherein the UVA sunscreen is 4-tert-butyl-4'-methoxydibenzoylmethane.
12.The sunscreen composition as per any one of claims 1 to 11, wherein the composition is a leave-on composition.
13.The sunscreen composition as per any one of claims 1 to 11, wherein the composition is a wash-off composition.
14.A method of providing improved UVAPF, wherein the method comprises the steps of:
a. applying on the skin a sunscreen composition as per any one of claims 1 to 13; and b. optionally, rinsing with water.
a. applying on the skin a sunscreen composition as per any one of claims 1 to 13; and b. optionally, rinsing with water.
15. Use of the composition as per any one of claims 1 to 13 for improved ultraviolet A protection factor.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18168640 | 2018-04-23 | ||
EP18168640.3 | 2018-04-23 | ||
PCT/EP2019/059662 WO2019206714A1 (en) | 2018-04-23 | 2019-04-15 | A sunscreen composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3095273A1 true CA3095273A1 (en) | 2019-10-31 |
Family
ID=62046690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3095273A Pending CA3095273A1 (en) | 2018-04-23 | 2019-04-15 | A sunscreen composition |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP3784355A1 (en) |
JP (1) | JP7362641B2 (en) |
KR (1) | KR20210005561A (en) |
CN (1) | CN112004579A (en) |
CA (1) | CA3095273A1 (en) |
EA (1) | EA202092522A1 (en) |
MX (1) | MX2020011125A (en) |
PH (1) | PH12020551441A1 (en) |
WO (1) | WO2019206714A1 (en) |
ZA (1) | ZA202005699B (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6869598B2 (en) * | 2002-03-22 | 2005-03-22 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Stabilization of sunscreens in cosmetic compositions |
JP4691464B2 (en) * | 2006-03-28 | 2011-06-01 | 株式会社資生堂 | Skin or hair composition |
WO2011147738A2 (en) | 2010-05-25 | 2011-12-01 | Unilever Nv | Sunscreen composition |
EP2431021A1 (en) | 2010-09-16 | 2012-03-21 | Unilever N.V. | Sunscreen composition |
MX2013004090A (en) * | 2010-10-12 | 2014-03-21 | Unilever Nv | A sunscreen composition. |
EP2789369B1 (en) * | 2013-04-14 | 2018-06-06 | Symrise AG | A composition for lightening skin and hair |
CN107405273B (en) * | 2015-03-10 | 2021-05-11 | 荷兰联合利华有限公司 | Personal care compositions |
-
2019
- 2019-04-15 WO PCT/EP2019/059662 patent/WO2019206714A1/en unknown
- 2019-04-15 KR KR1020207027996A patent/KR20210005561A/en not_active Application Discontinuation
- 2019-04-15 CA CA3095273A patent/CA3095273A1/en active Pending
- 2019-04-15 MX MX2020011125A patent/MX2020011125A/en unknown
- 2019-04-15 CN CN201980027747.7A patent/CN112004579A/en active Pending
- 2019-04-15 EP EP19716447.8A patent/EP3784355A1/en active Pending
- 2019-04-15 EA EA202092522A patent/EA202092522A1/en unknown
- 2019-04-15 JP JP2020551399A patent/JP7362641B2/en active Active
-
2020
- 2020-09-08 PH PH12020551441A patent/PH12020551441A1/en unknown
- 2020-09-14 ZA ZA2020/05699A patent/ZA202005699B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2021519277A (en) | 2021-08-10 |
PH12020551441A1 (en) | 2021-08-23 |
KR20210005561A (en) | 2021-01-14 |
EP3784355A1 (en) | 2021-03-03 |
JP7362641B2 (en) | 2023-10-17 |
WO2019206714A1 (en) | 2019-10-31 |
CN112004579A (en) | 2020-11-27 |
MX2020011125A (en) | 2020-11-11 |
ZA202005699B (en) | 2022-09-28 |
EA202092522A1 (en) | 2021-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210106509A1 (en) | A sunscreen composition | |
AU2007287653B2 (en) | Photostable cosmetic compositions | |
BR112021007957B1 (en) | LIQUID AND TRANSPARENT MIXTURE OF UV FILTERS, COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITION AND USE OF THE MIXTURE OR COMPOSITION | |
EP2771072B1 (en) | An aqueous photo-protective personal care composition | |
EP2654688B1 (en) | A high spf sunscreen composition | |
WO2020030396A1 (en) | A topical composition | |
CA2788030C (en) | A photostable sunscreen composition | |
BR112015017297B1 (en) | COSMETIC OR DERMATOLOGICAL COMPOSITION AND NON-THERAPEUTIC COSMETIC PROCESSES | |
CA3095273A1 (en) | A sunscreen composition | |
EA046155B1 (en) | SUN PROTECTION COMPOSITION | |
EP2724709A1 (en) | A sunscreen composition containing ester salts of L-DOPA | |
WO2021234005A1 (en) | A personal care composition | |
WO2021249760A1 (en) | A cosmetic composition comprising 6-methyl-picolinamide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20231108 |
|
EEER | Examination request |
Effective date: 20231108 |